Stay updated on Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.

Latest updates to the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%

- Check26 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - Added new contact numbers (646-888-4206, 646-888-4197, 646-888-4188). - Removed reference to the old revision (v3.0.2).SummaryDifference0.1%

- Check41 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the 'Back to Top' element has been removed.SummaryDifference0.1%

- Check48 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check55 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of cabozantinib. The revision number has also been updated to v3.0.0.SummaryDifference2%

- Check69 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.